Upcoming Conferences

Data demonstrating that CBF measured by CerOx correlates with measurements by Xe-SPECT will be presented at the 10th annual meeting of the Neurocritical Care Society in Denver, Oct 3-7 2012. Data from a clinical study at Duke MC, demonstrating that cerebral oximetry monitored using CerOx is comparable to TCD in detecting cerebral vasospasm will be presented at 10th annual meeting of the Neurocritical Care Society, Denver, Oct 3-7 2012